×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| AUROBINDO PHARMA LTD. | 81,358.10 | 8,455.70 | 79,785.20 | 14.56 | 65,062 | 18.3 |
| ABBOTT INDIA LTD. | 16,860.30 | 3,607.80 | 16,142.80 | 169.78 | 62538 | 46.9 |
| Alkem Laboratories Limited | 34672.7 | 6407.9 | 33742.8 | 52.34 | 55290 | 25.6 |
Aurobindo Pharma Ltd., with Security Code 524804, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,786.9 | 3,025.6 | 3,432.2 | 3,547.4 | 2,390.8 | 2,668.7 | 2,692.0 | 2,894.0 | 2,460.0 | 2,824.5 |
| Expenses | 2,544.7 | 2,729.8 | 2,959.0 | 2,855.6 | 1,968.4 | 2,123.6 | 2,210.3 | 2,119.2 | 1,961.2 | 2,103.7 |
| Operating Profit | 242.3 | 295.9 | 473.2 | 691.8 | 422.4 | 545.2 | 481.7 | 774.8 | 498.9 | 720.9 |
| OPM % | 8.69% | 9.78% | 13.79% | 19.5% | 17.67% | 20.43% | 17.89% | 26.77% | 20.28% | 25.52% |
| Other Income | 38.7 | 55.9 | 78.7 | 288.2 | 94.9 | 67.1 | 331.1 | 123.0 | 65.3 | 122.7 |
| Interest | 7.9 | 19.2 | 39.0 | 49.0 | 31.6 | 36.7 | 61.3 | 53.1 | 51.1 | 51.6 |
| Depreciation | 103.1 | 108.8 | 108.5 | 115.0 | 59.6 | 65.8 | 64.4 | 64.8 | 66.9 | 68.2 |
| Profit before tax | 170.1 | 223.8 | 404.5 | 816.0 | 426.0 | 509.8 | 687.2 | 779.9 | 446.2 | 723.8 |
| Tax % | 28.2% | 26.4% | 26.1% | 21% | 25.4% | 25.5% | 9.2% | 25.8% | 26.3% | 25.7% |
| Net Profit | 122.2 | 164.6 | 298.8 | 644.8 | 336.0 | 415.7 | 623.8 | 578.7 | 329.0 | 537.5 |
| EPS in Rs | 2.08 | 2.81 | 5.1 | 11 | 5.74 | 7.1 | 10.65 | 9.88 | 5.62 | 9.21 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,739.4 | 6,407.1 | 6,473.0 | 6,850.5 | 7,219.4 | 7,351.8 | 7,580.2 | 7,567.0 | 7,796.1 | 7,978.5 |
| Expenses | 4,949.8 | 5,453.3 | 5,476.6 | 5,702.0 | 5,846.0 | 5,753.1 | 5,920.0 | 5,948.8 | 6,229.9 | 6,400.5 |
| Operating Profit | 789.6 | 953.8 | 996.3 | 1,148.6 | 1,373.4 | 1,598.7 | 1,660.2 | 1,618.2 | 1,566.1 | 1,578.0 |
| OPM % | 13.8% | 14.9% | 15.4% | 16.8% | 19% | 21.7% | 21.9% | 21.4% | 20.1% | 19.8% |
| Other Income | 57.2 | 92.7 | 134.9 | 46.6 | 187.0 | 162.5 | 13.5 | 220.9 | 136.0 | 157.3 |
| Interest | 25.3 | 45.0 | 55.6 | 56.6 | 68.2 | 75.6 | 89.4 | 111.0 | 112.7 | 118.5 |
| Depreciation | 298.1 | 321.4 | 345.6 | 326.6 | 417.5 | 423.3 | 354.3 | 404.2 | 382.3 | 418.5 |
| Profit before tax | 523.4 | 680.1 | 730.1 | 881.8 | 1,074.7 | 1,262.4 | 1,352.0 | 1,323.9 | 1,207.2 | 1,198.3 |
| Tax % | 21.5% | 27.8% | 30.5% | 29.7% | 30.1% | 25.5% | 26% | 30.6% | 32.3% | 29.6% |
| Net Profit | 410.4 | 491.0 | 505.9 | 569.7 | 751.9 | 940.0 | 907.4 | 918.2 | 817.0 | 845.6 |
| EPS in Rs | 6 | 8 | 8 | 9 | 12 | 16 | 15 | 15 | 14 | 14 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -3% |
| 3 Years: | -12% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 5% |
| 3 Years: | -14% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 21% |
| 1 Year: | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 6% |
| 3 Years: | -1% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 21% |
| 1 Year: | 8% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|